Cellectar Biosciences: In Connection With The Reverse Stock Split, Every 30 Shares Of The Company’s Common Stock Issued And Outstanding As Of The Effective Time Will Be Automatically Converted Into One Share Of The Company’s Common Stock. Stockholders Who Would Otherwise Hold A Fractional Share Of Common Stock Will Receive A Cash Payment In Lieu Of Such Fractional Share, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Cellectar Biosciences, Inc.
• Paese di registrazione
  USA
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***